Corrections officer Anthony Willingham displays Naloxone nasal spray, part of an opioid anti-overdose medicine kit for inmates to take with them upon release, before a training session for inmates at the Queensboro Correctional Facility in Queens, New York, U.S., April 9, 2018. REUTERS/Shannon Stapleton
NEW YORK (Reuters) - The inmates filed into a room at a New York prison, squeezed into classroom-style desks, and watched a guard demonstrate how a small plastic tube could help them save lives when they return to the streets of a nation gripped by an opioid epidemic.
The weekly class at the Queensboro Correctional Facility in New York City is part of a state programme to expand access to naloxone, a drug delivered through a nasal spray that can quickly revive someone who is overdosing on heroin or an opioid-based prescription painkiller.
Limited time offer:
Just RM5 per month.
